Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy-Reference-Cited by-同舟云学术

Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy

Published:2024-07 Issue:2 Volume:167 Page:281-297
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Xie Yongjie,Zhou Tianxing,Li Xueyang,Zhao Kaili,Bai Weiwei,Hou Xupeng,Liu Ziyun,Ni Bo,Zhang Zhaoyu,Yan Jingrui,Wang Yifei,Jiang Wenna,Wang Hongwei,Chang Antao,Gao Song,Zhao Tiansuo,Yang Shengyu,Huang Chongbiao,Liu Jing,Hao Jihui

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference29 articles.

1. Pancreatic cancer: a review of epidemiology, trend, and risk factors;Hu;World J Gastroenterol,2021

2. First-line gemcitabine and nab-paclitaxel chemotherapy for localized pancreatic ductal adenocarcinoma;Gulhati;Ann Surg Oncol,2019

3. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine;Von Hoff;N Engl J Med,2013

4. Pancreatic cancer chemoresistance to gemcitabine;Amrutkar;Cancers (Basel),2017

5. Trial watch: the clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors;Tang;Nat Rev Drug Discov,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The aminophospholipid transporter, ATP8B3, as a potential biomarker and target for enhancing the therapeutic effect of PD-L1 blockade in colon adenocarcinoma;Genomics;2024-09

2. The complex interplay of tumor-infiltrating cells in driving therapeutic resistance pathways;Cell Communication and Signaling;2024-08-19

3. Unbiasedly decoding the tumor microenvironment with single-cell multiomics analysis in pancreatic cancer;Molecular Cancer;2024-07-09